 |
Betahistine dihydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Prader-Willi syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2007-11-08 00:00:00 |
| Sponsor | Floyd R. Sallee, M.D., Ph.D.;University of Cincinnati School of Medicine, ML 0559;Cincinnati, Ohio, 45267 |
